Unlike LRRK2, PINK1 mutations reduce kinase activity and cause an atypical form of PD characterized by an early age of onset and slower clinical progression (Abou-Sleiman et al., 2006; Woodroof et al., 2011). Here, PINK1 is linked to Parkinson disease.